Delivery Order SPE2DB22D1106-SPE2DB25FERL6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,914.75 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 100 mg, a controlled-release pain management pharmaceutical. This contract type delivery order carries firm fixed pricing and was competitively awarded with no set-aside designation. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 17, 2025. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,899.74 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract action under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,101.84 for Nucynta ER Tabs 250mg, a pain management pharmaceutical. This competitively awarded, firm fixed-price delivery order was issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,531.10 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 150 mg, a prescription opioid pain management medication. The award, made on May 20, 2025, with completion targeted for May 21, 2025, utilized firm fixed price contracting with no set-aside designation, indicating competitive award procedures. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of Nucynta 75 mg tablets (100 count) valued at $1,432.38 under a firm fixed price contract. The award, issued on July 30, 2025, with a completion date of July 31, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,367.15 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count) on August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and will be performed at the awardee's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,416.12 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 100 mg tablets (60-count packages) on August 20, 2025, with a completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $7,070.28 to AmerisourceBergen Drug Corp for Nucynta Tabs 100mg, a prescription pain management medication. This competitively awarded, firm fixed-price contract was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,810.39 for 60-count tablets of Nucynta ER 50 mg, an opioid pain management medication. Issued on September 4, 2025, with an ultimate completion date of September 5, 2025, this firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract will be performed at the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.17 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 150 mg tablets (60-count units) on June 20, 2025, with an ultimate completion date of June 23, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FERL6Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,194.33 to AmerisourceBergen Drug Corp for 60 tablets of Nucynta ER 50 mg, a controlled-release pain management pharmaceutical. The contract was competitively awarded without set-aside provisions under a firm fixed price arrangement, with performance scheduled for completion by June 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this medical supply delivery. This delivery order represents a transaction under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal procurement portfolio demonstrates extensive experience fulfilling Defense Logistics Agency medical supply requirements across multiple therapeutic domains, positioning the company as a critical vendor for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/3/25 |